NCT06711952Recruiting
German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)
German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q) and Its Potential Use in Large Cohorts
Source: ClinicalTrials.gov · Last updated 29 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 21 Dec 2023
- Start date
- 1 Feb 2023
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Diseases
- Alzheimer disease
- NCT number
- NCT06711952
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 1 Feb 2023 to the primary completion date, 31 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- dementia in a very advance stage
Other
- Illiteracy
Who the study is looking for
- Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
- Provision of signed, written and dated informed consent
- Capacity to give informed consent
Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums Coordinator of this site? Confirm its status | München | Germany | Recruiting |
Related publications
- Diagnostic accuracy of a self-administered digital cognitive test battery for differentiating early Alzheimer's disease from controls.Eur Arch Psychiatry Clin Neurosci · 2026 · PMID 42608580
This page is information, not medical advice. Discuss any trial with your doctor.